CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
93.72
+0.07 (0.07%)
Aug 20, 2026, 12:05 PM EDT - Market open

CVS Health Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
11,3298,4538,5868,19612,9459,408
Short-Term Investments
2,6292,1452,4073,2592,7783,117
Cash & Short-Term Investments
13,95810,59810,99311,45515,72312,525
Cash Growth
-1.52%-3.59%-4.03%-27.15%25.53%15.39%
Accounts Receivable
19,38016,31614,61215,62227,27621,042
Other Receivables
20,92923,46321,85719,605-3,389
Receivables
40,30939,77936,46935,22727,27624,431
Inventory
17,62219,24618,10718,02519,09017,760
Restricted Cash
-5995901443,065
Other Current Assets
3,4575,0322,9813,0613,4002,227
Total Current Assets
75,34674,71468,64567,85865,63360,008
Property, Plant & Equipment
27,61928,05628,93730,43530,74532,018
Long-Term Investments
33,24732,66928,93423,01921,09623,025
Goodwill
85,47885,47891,27291,27278,15079,121
Other Intangible Assets
24,64425,50827,32329,23424,80329,026
Other Long-Term Assets
7,4347,1138,1047,9107,8489,801
Total Assets
253,768253,538253,215249,728228,275232,999

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
17,16717,64115,89214,89714,83812,544
Accrued Expenses
38,79037,72435,73035,41528,81626,391
Short-Term Debt
--2,119200--
Current Portion of Long-Term Debt
1,9584,0073,5592,7061,7194,155
Current Portion of Leases
1,9141,7981,8161,8071,7371,696
Current Unearned Revenue
-621441497187
Other Current Liabilities
27,21227,46025,34924,01522,24022,934
Total Current Liabilities
87,04188,69284,60979,18969,42167,807
Long-Term Debt
59,45259,23759,23257,31349,07050,721
Long-Term Leases
12,98214,90816,19417,35918,20619,427
Pension & Post-Retirement Benefits
-165169189197250
Long-Term Deferred Tax Liabilities
3,7663,8323,8064,3114,0166,270
Other Long-Term Liabilities
10,62811,32213,47514,73115,59613,143
Total Liabilities
173,869178,156177,485173,092156,506157,618

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
181818181817
Additional Paid-In Capital
50,95050,38449,64348,97448,17547,360
Retained Earnings
65,39861,19662,83761,60456,39854,906
Treasury Stock
-36,852-36,790-36,818-33,838-31,829-28,144
Comprehensive Income & Other
188406-120-297-1,293936
Total Common Equity
79,70275,21475,56076,46171,46975,075
Minority Interest
197168170175300306
Shareholders' Equity
79,89975,38275,73076,63671,76975,381
Total Liabilities & Equity
253,768253,538253,215249,728228,275232,999

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
76,30679,95082,92079,38570,73275,999
Net Cash (Debt)
-62,348-69,352-71,927-67,930-55,009-63,474
Net Cash Growth
------
Net Cash Per Share
-48.75-54.56-56.99-52.66-41.58-47.76
Filing Date Shares Outstanding
1,2791,2721,2611,2581,2841,313
Total Common Shares Outstanding
1,2781,2711,2601,2881,3001,322
Working Capital
-11,695-13,978-15,964-11,331-3,788-7,799
Book Value Per Share
62.3659.1859.9759.3654.9856.79
Tangible Book Value
-30,420-35,772-43,035-44,045-31,484-33,072
Tangible Book Value Per Share
-23.80-28.14-34.15-34.20-24.22-25.02
Land
-1,8091,8471,9581,9962,038
Buildings
-4,5934,6324,5714,5454,225
Machinery
-11,73711,71611,02412,73413,619
Leasehold Improvements
-6,8126,7256,5116,2386,242
SEC Filings: 10-K · 10-Q